Spectral AI, Inc. (MDAI) Stock Score, Valuation & Financial Research
Spectral AI, Inc. is in the Healthcare sector and Medical - Specialties industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 21/100.
Quick answer for MDAI
Spectral AI, Inc. currently has a Wall Street Score of 21/100. The stored market price is $1.55. Its financial score is 22/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Spectral AI, Inc. does
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
MDAI financial snapshot
- Wall Street Score:
- 21/100
- Current price:
- $1.55
- Market capitalization:
- $49.3M
- Revenue:
- $16.7M
- Net income:
- $-14.3M
- Free cash flow:
- $-9.9M
- Cash:
- $11.7M
- Total debt:
- $9.9M
- EPS:
- -0.29
- Financial score:
- 22/100
- Valuation score:
- 0/100
- Revenue score:
- 7/100
What stands out
- Reported year-over-year revenue growth is -0.2%.
- Free cash flow is $-9.9M, showing cash burn in the current stored period.
- The balance sheet shows $11.7M of cash versus $9.9M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 22/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MDAI
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.